Helen McShane

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 13

Top Venues

Wellcome open research

NPJ vaccines

Expert review of vaccines

Nature medicine

University of Oxford

University of London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Oxford

United Kingdom

Professor of Vaccinology :: Jenner

University of Oxford

United Kingdom

Wellcome Trust Senior Clinical Research Fellow

Oxford University Hospitals NHS Trust

United Kingdom

Honorary Consultant in GU & HIV Medicine

University of Oxford

United Kingdom

Reader in Vaccinology :: Jenner

University of Oxford

United Kingdom

Honorary Research Lecturer

Centre for Clinical Vaccinology and Tropical Medicine

United Kingdom

Wellcome Clinician Scientist

Nuffield Department of Clinical Medicine

United Kingdom

MRC Clinical Training Fellow

Middlesex University

United Kingdom

Specialist Registrar in HIV and GU Medicine

Churchill Hospital

United Kingdom

Registrar in Infectious Diseases

Education History

University of London

United Kingdom

PHD :: Nuffield Department of Medicine, Oxford

University of London

United Kingdom

BSC :: Guys Hospital Medical School

Publications

Stephen Brian Gordon, Simon Sichone, Anthony E Chirwa, Phoebe Hazenberg, Zacharia Kafuko, Daniela M Ferreira, Joanne Flynn, Sarah Fortune, Shobana Balasingam, Giancarlo A Biagini, Helen McShane, Henry Mwandumba, Kondwani C Jambo, Keertan Dedha, Nimisha Raj Sharma, Brian D Robertson, Naomi Walker, Ben Morton, null null
Practical considerations for a TB controlled human infection model (TB-CHIM); the case for TB-CHIM in Africa, a systematic review of the literature and report of 2 workshop discussions in UK and Malawi. Wellcome open research 8 (2023)
Iman Satti, Rachel E Wittenberg, Shuailin Li, Stephanie A Harris, Rachel Tanner, Deniz Cizmeci, Ashley Jacobs, Nicola Williams, Humphrey Mulenga, Helen A Fletcher, Thomas Jens Scriba, Michele Tameris, Mark Hatherill, Helen McShane
Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants. Nature communications 13 (1) (2022)
Poppy Brown, Felicity Waite, Michael Larkin, Sinead Lambe, Helen McShane, Andrew J Pollard, Daniel Freeman
" It seems impossible that it's been made so quickly ": a qualitative investigation of concerns about the speed of COVID-19 vaccine development and how these may be overcome. Human vaccines & immunotherapeutics 18 (1) (2022)
Ben Killingley, Alexander Mann, Mariya Kalinova, Alison Boyers, Niluka Goonawardane, Jie Zhou, Kate Lindsell, Samanjit S Hare, Jonathan C Brown, Rebecca Frise, Emma Smith, Claire Hopkins, Nicolas Noulin, Brandon Löndt, Tom Wilkinson, Stephen Harden, Helen McShane, Mark Baillet, Anthony Gilbert, Michael Jacobs, Christine Charman, Priya Mande, Jonathan S Nguyen-Van-Tam, Malcolm Gracie Semple, Robert Charles Read, Neil M Ferguson, Peter J M Openshaw, W Garth Rapeport, Wendy S Barclay, Andrew P Catchpole, Christopher Chiu
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults. Nature medicine 28 (5) (2022)
Lauren Wedekind, Andrés Noé, Jolynne Mokaya, Cynthia Tamandjou, Melissa C Kapulu, Andrea Ruecker, Evelyne Kestelyn, Machilu Zimba, Elham Khatamzas, Alice Chi Eziefula, Claire L Mackintosh, Roger Nascimento, Proochista Ariana, Denise Best, Edward Gibbs, Susanna J Dunachie, Gina Hadley, Hannah Ravenswood, Bernadette C Young, Charles Kamau, Kevin Marsh, Helen McShane, Rob Hale, Elena McPhilbin, Pavel V Ovseiko, null null, Rebecca Surender, Claire Worland, Lisa Jane White, Philippa Clare Matthews
Equity for excellence in academic institutions: a manifesto for change. Wellcome open research 6 (2021)
Rachel Tanner, Andrew D White, Charelle Boot, Claudia C Sombroek, Matthew K O'Shea, Daniel Wright, Emily Hoogkamer, Julia Bitencourt, Stephanie A Harris, Charlotte Sarfas, Rachel E Wittenberg, Iman Satti, Helen A Fletcher, Frank A W Verreck, Sally A Sharpe, Helen McShane
A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates. NPJ vaccines 6 (1) (2021)
Paulo J G Bettencourt, Julius Müller, Annalisa Nicastri, Daire Cantillon, Meera Madhavan, Philip D Charles, Carine B Fotso, Rachel E Wittenberg, Naomi Bull, Nawamin Pinpathomrat, Simon J Waddell, Elena Stylianou, Adrian V S Hill, Nicola Ternette, Helen McShane
Identification of antigens presented by MHC for vaccines against tuberculosis. NPJ vaccines 5 (1) (2020)
Helen McShane
Controlled Human Infection Models: Is it Really Feasible to Give People Tuberculosis? American journal of respiratory and critical care medicine 201 (10) (2020)
Lorna R Henderson, Syed Ghulam Sarwar Shah, Pavel V Ovseiko, Rinita Dam, Alastair M Buchan, Helen McShane, Vasiliki Kiparoglou
Markers of achievement for assessing and monitoring gender equity in a UK National Institute for Health Research Biomedical Research Centre: A two-factor model. PloS one 15 (10) (2020)
Elena Stylianou, Matthew J Paul, Rajko Reljic, Helen McShane
Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges. Expert review of vaccines 18 (12) (2019)
Zita-Rose Manjaly Thomas, Iman Satti, Julia L Marshall, Stephanie A Harris, Raquel Lopez Ramon, Ali Hamidi, Alice Minhinnick, Michael Riste, Lisa K Stockdale, Alison M Lawrie, Samantha Vermaak, Morven Wilkie, Henry Bettinson, Helen McShane
Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial. PLoS medicine 16 (4) (2019)
Iman Satti, Helen McShane
Current approaches toward identifying a correlate of immune protection from tuberculosis. Expert review of vaccines 18 (1) (2018)
Anne Wajja, Milly Namutebi, Barbara Apule, Gloria Oduru, Samuel Kiwanuka, Mirriam Akello, Beatrice Nassanga, Joyce Kabagenyi, Juma Mpiima, Samantha Vermaak, Alison Lawrie, Iman Satti, Jaco Verweij, Stephen Cose, Jonathan Levin, Pontiano Kaleebu, Edridah Tukahebwa, Helen McShane, Alison M Elliott
Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A. Wellcome open research 3 (2018)

Helen McShane.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Helen McShane